Concateno, a subsidiary of Alere™ Inc., brings together what it describes as Europe’s strongest and most experienced drug and alcohol testing organisations, with more than 60 years’ collective expertise.
Concateno is on call around the clock every day of the year and performs some 10 million tests annually. The company will be showcasing the latest in its range of testing products designed to help organisations understand their situation, exercise their responsibilities and take appropriate actions to manage the risk of drug and alcohol misuse at work.
These will include: the Alcolock® GB Breathalyser Immobiliser System, said to stop drink driving in its tracks; the Alere™ DDS®2 Mobile Test System, an oral fluid drug-testing system said to allow on-the-spot screening in three easy steps; and the Concateno Instrumented Test System with DxLINK™ Technology, which provides automated results interpretation for urine-screening devices.
For more, go to www.concateno.com
